Replies to post #2669 on Idenix Pharmaceuticals (IDIX)

[rkrw]

Albuferon seems unlikely to do well. To date as far as I can tell nvs has got very little return in hcv having spent easily well over a billion.

Cut bait as in not support idix any more. If/when idix raises more capital if nvs keeps their pro rata it would be a good sign and vice versa.

[pollyvonwog]

Due, seeing as you expected a much higher floor in the pps, what do you think has caused this rather large drop to bring us to the 2.50 range (52 week low). TIA